The uncertain science of preimplantation genetic testing in Japan. Correspondence from Mayumi Sugiura-Ogasawara & Takeshi Sato, Nagoya City University, Japan
about the uncertain science of preimplantation genetic testing . Japan is unique in its approach to reproductive medicine in that it does not have laws regulating such testing, and instead physicians are self-regulated according to principles formulated by the Japan Society of Obstetrics and Gynecology .
Patient groups for neuromuscular diseases, Down’s syndrome and other disorders have been against the use of preimplantation genetic testing for monogenic defects . The JSOG made a rule in 1998 that each proposed instance of such testing must be submitted to and reviewed by committee. On the basis of the review, only patients with extremely severe genetic disease and recurrent pregnancy loss caused by translocation have been permitted to use PGT in Japan.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Predicting chronic morbidity in childhood cancer survivors - Nature MedicineNews & Views: Survivors of childhood cancer have high rates of morbidity in later life. LInda Vrooman and Lisa Diller DanaFarber BostonChildrens discuss models to predict severe obesity, which could promote early interventions & better long-term care.
Read more »
Next steps for the xenotransplantation of pig organs into humans - Nature MedicinePigs offer a potentially plentiful supply of organs for humans, but widespread xenotransplantation will require a collaborative and iterative approach to research, as well as involvement of transplant patients and the public.
Read more »
Make deep learning algorithms in computational pathology more reproducible and reusable - Nature MedicineGreater emphasis on reproducibility and reusability will advance computational pathology quickly and sustainably, ultimately optimizing clinical workflows and benefiting patient health.
Read more »
Choosing Wisely for oncology in Brazil: 10 recommendations to deliver evidence-based cancer care - Nature MedicineChoosing Wisely for oncology in Brazil: 10 recommendations to deliver evidence-based cancer care. Correspondence from Fabio Ynoe de Moraes and colleagues LACOG_group
Read more »
Pepinemab antibody blockade of SEMA4D in early Huntington’s disease: a randomized, placebo-controlled, phase 2 trial - Nature MedicineThe SIGNAL Phase 2 study of pepinemab immunotherapy in early Huntington’s disease (HD) did not meet its coprimary clinical efficacy endpoints, but had a favorable safety profile and showed a significant treatment-related reduction in caudate brain atrophy and reversal of the characteristic decline in brain metabolic activity that is typical of HD progression.
Read more »
Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial - Nature MedicineFindings from the TUXEDO-1 trial demonstrate efficacy of the antibody-drug conjugate trastuzumab deruxtecan for treatment of brain metastases in patients with HER2-positive BreastCancer. CNS Cancer NMEDClinical MedUni_Wien
Read more »